Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Kaleido Biosciences Inc..
Kaleido Biosciences Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Kaleido Biosciences Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Kaleido Biosciences Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Kaleido Biosciences Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Kaleido Biosciences Inc. and all latest updates of the company are provided.
The 2025 version of Kaleido Biosciences Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Kaleido Biosciences Inc.- Key Facts
2.2 Kaleido Biosciences Inc.- Geographic Locations
2.3 Kaleido Biosciences Inc.- Subsidiaries and Affiliates
2.4 Kaleido Biosciences Inc.- Business Divisions
2.5 Kaleido Biosciences Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Kaleido Biosciences Inc. Strategic Analysis Review
3.1 Kaleido Biosciences Inc.- Key Strategies
3.2 Kaleido Biosciences Inc.- Company Outlook Statement
3.3 Kaleido Biosciences Inc.- SWOT Analysis
3.3.1 Kaleido Biosciences Inc.- Key Strengths
3.3.2 Kaleido Biosciences Inc.- Key Weaknesses
3.3.3 Kaleido Biosciences Inc.- Potential Opportunities
3.3.4 Kaleido Biosciences Inc.- Potential Threats
3.4 Kaleido Biosciences Inc.- Key Competitors
4. Business Description of the Company
4.1 Kaleido Biosciences Inc.- Business Overview
4.2 Kaleido Biosciences Inc.- Operations by Segment
5 Products and Services Details
5.1 Kaleido Biosciences Inc.- Key Products
5.2 Kaleido Biosciences Inc.- Key Service Areas
5.3 Kaleido Biosciences Inc.- Key Brands
6 Company Developments
6.1 Kaleido Biosciences Inc.- Company History
6.2 Kaleido Biosciences Inc.- Latest Developments
7 Financial Analysis
7.1 Kaleido Biosciences Inc.- Income Statements
7.2 Kaleido Biosciences Inc.- Balance Sheet
7.3 Kaleido Biosciences Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Kaleido Biosciences Inc.- Direct Competitors
8.2 Kaleido Biosciences Inc.- Competitor Financial Ratios comparison
8.3 Kaleido Biosciences Inc.- Competitor Stock Charts Comparison
8.4 Kaleido Biosciences Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!